FMP
VolitionRx Limited
VNRX
AMEX
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
0.494 USD
0.034 (6.88%)
Balance Sheet
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Total Cash
1.24B
1.15B
1.2B
2.95B
2.17B
937.84M
1.09B
1.27B
1.47B
1.71B
Total Cash %
263.37
219.67
160.65
320.52
269.4
100
100
100
100
Receivables
79M
102.3M
150.2M
265.3M
289.8M
227.06M
263.81M
306.51M
356.11M
413.75M
Receivables %
16.78
19.46
20.13
28.78
35.9
24.21
24.21
24.21
24.21
Inventories
121.9M
166.6M
227M
327.5M
461.2M
338.89M
393.74M
457.47M
531.5M
617.53M
Inventories %
25.9
31.7
30.42
35.52
57.14
36.14
36.14
36.14
36.14
Payable
88.1M
44.2M
57.8M
44.9M
53M
86.86M
100.92M
117.25M
136.23M
158.28M
Payable %
18.72
8.41
7.75
4.87
6.57
9.26
9.26
9.26
9.26
Cap Ex
-234.3M
-576.4M
-650.6M
-962.3M
-2.27B
-819.61M
-952.26M
-1.11B
-1.29B
-1.49B
Cap Ex %
-49.78
-109.67
-87.19
-104.38
-281.71
-87.39
-87.39
-87.39
-87.39
